9
compounds with the functionality at C7 moved to C5, have
and C-10 positions of allocolchicinoids from a common
starting material, namely, carbene complexes of type 2b.
Furthermore, the presence of oxygen functionalities in the
C-8 and C-11 positions on ring C of the allocolchicinoids
of type 3b allows for the preparation of the corresponding
triflates, which can be either catalytically coupled with
been recently prepared but found not to affect the tubulin
polymerization process, despite their narrow structural
similarity with the active allocolchicinoids. It was also shown
that any alteration to the trioxygenated moiety of ring A leads
to compounds with decreased tubulin-binding ability. In
contrast, the biological activity of ring C substituted allo-
colchicinoids varies with size, position, and nature of the
substituents.6
1
0
1
4
15
organometallic reagents or reduced, giving a variety of
C-8 and C-11 functionalized allocolchicinoids. In addition,
it should be possible to readily access optically pure
substrates of type 1b. A straightforward approach would be
,11
It was found that only natural (-)-(7S)-colchicine, which
adopts an aR biaryl configuration, binds effectively to tubulin.
The aS,7R-enantiomer does not interfere with the tubulin
polymerization process. Although 7S-allocolchicinoids prefer
an aR biaryl configuration, they exist in solvent-dependent
equilibrium between aR and aS forms and several active 7R
1
6
an oxidation-asymmetric reduction sequence on the cor-
responding alcohol, followed by alkylation. The presence of
a C-11 substituent, which is introduced in the ring C
annulation process, will stop the epimerization about the
chiral axis. Therefore, aR and aS forms of such allocolchi-
cinoids could be isolated and separately subjected to biologi-
cal testing. The development of a successful protection-
deprotection routine for the hydroxy group at C-7 will be
critical for the introduction of other functional groups at C-7
which are not compatible with the carbene complex prepara-
tion conditions. This would include the acyl, aroyl, or
acetamido groups that occur in natural allocolchicinoids.
The proposed reaction sequence was first tested on the
unsubstituted ring C model compounds 1a-3a (Scheme 1).
5
allocolchicinoids are known. It is still not clear whether the
aR,7S form or the small amount of the aS,7S form, present
in solution in equilibrium, is active in the tubulin-binding
process. Because of its high toxicity, colchicine cannot be
used as a therapeutic drug for treatment of human cancers.
Despite the amount of work that has been directed to
structural modification and synthesis of new colchicinoids
and allocolchicinoids, greatly improved active compounds
have not been identified, mainly because of the difficulties
associated with the construction of highly functionalized ring
C derivatives. To date, only a limited number of reports
describe synthetic pathways toward the preparation of
Scheme 1. Synthesis of Biaryl Phenol 3aa
1
1,12
allocolchicinoids,
and the vast majority of these com-
pounds are still being prepared from natural (-)-colchicine.
No general methodology exists for the efficient construction
of different ring C functionalized allocolchicinoids, which
would be desirable in the search to find more active and
less toxic antimitotic agents and to acquire structure-activity
information about the requirements for binding to tubulin.
We now report a novel approach toward the highly
convergent construction of allocolchicinoids of type 3 which
have the natural substitution pattern on ring A and which
provide for a controlled variability of functionalization on
ring C. This family of allocolchicinoids should be accessible
in one step from Fischer carbene complexes of type 2 by
their benzannulation reaction13 with acetylenes, where the
regiochemistry of the acetylene incorporation is controlled
a
(
i) AgBF
ether, 15 min, (2) Cr(CO)
MeOTf, CH Cl , 25 °C, 1.5 h, 66%; (iii) (1) 3 equiv of 1-pentyne,
4
, MeOH, reflux 24 h, 92%; (ii) (1) t-BuLi, -78 °C,
6
, ether, 0 °C 0.5 h, 25 °C, 1.5 h, (3)
2
2
hexane, 50 °C, 24 h, (2) air, 25 °C, 12 h, 65%.
L S
by the steric size of large (R ) and small (R ) groups on the
acetylene. This methodology will provide for a rapid
introduction of a variety of different substituents in the C-9
Access to 1a was achieved by electrophilic ring opening of
1
7
the known dibromocyclopropane 8a mediated by a silver
salt in methanol which readily provided bromide 1a. Ap-
plication of the modified Fischer procedure to the substrate
(6) Banwell, M. G.; Cameron, J.; Corbett, M.; Dupuche, J. R.; Hamel,
E.; Lambert, J. N.; Lin, C. M.; Mackay, M. F. Aust. J. Chem. 1992, 45,
1
967.
(
(
7) Berg, U.; Bladh, H. Acta Chem. Scand. 1998, 52, 1380.
8) Brecht, R.; Seitz, G.; Guenard, D.; Thoret, S. Bioorg. Med. Chem.
(14) For successful coupling, in situ triflation of the intermediate
chromium tricarbonyl complex of 3 must be performed, which can be
isolated and subjected to Suzuki or Stille coupling conditions as we have
previously reported. The free allocolchicinoids can then be generated by
oxidative removal of the Cr(CO)3 group using iodine. Gilbert, A. M.; Wulff,
W. D. J. Am. Chem. Soc. 1994, 116, 7449.
(15) For example, HCOOH in the presence of Pd(dppf)Cl2 catalyst and
Et3N has previously been used in a synthesis of the tricyclic core of olivin.
Miller, R. A.; Gilbert, A. M.; Xue, S.; Wulff, W. D. Synthesis 1998, 80.
(16) For asymmetric catalytic reduction of R-bromoenones with the CBS
reagent, see: Corey, E. J.; Bakshi, R. K.; Shibata, S.; Chen, Ch.-P.; Singh,
V. K. J. Am. Chem. Soc. 1987, 109, 7925.
2
000, 8, 557.
9) Boye, O.; Brossi, A.; Yeh, H. J. C.; Hamel, E.; Wegrzynski, B.;
Toome, V. Can. J. Chem. 1992, 70, 1237.
10) Banwell, M. G.; Cameron, J. M.; Collins, M. P.; Crisp, G. T.; Gable,
R. W.; Hamel, E. Aust. J. Chem. 1991, 44, 705.
11) Banwell, M. G.; Fam, M.-A.; Gable, R. W.; Hamel, E. J. Chem.
Soc., Chem. Commun. 1994, 2647.
(
(
(
(
12) Sawyer, J. S.; Macdonald, T. L. Tetrahedron Lett. 1988, 29, 4839.
(13) For reviews on Fisher carbene complexes and their transformations,
see: (a) Herndon, J. W. Coord. Chem. ReV. 1999, 181, 177. (b) Wulff, W.
D. In ComprehensiVe Organometallic Chemistry II; Elsevier Science Ltd.:
Oxford, England; 1995; Vol. 12, p 469.
(17) Riley, P. E.; Davis, R. E.; Allison, N. T.; Jones, W. M. J. Am. Chem.
Soc. 1980, 102, 2458.
2642
Org. Lett., Vol. 3, No. 17, 2001